Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Nathan S Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA. citrome@nki.rfmh.org
Five new antipsychotic drugs introduced in the United States in the last decade offer physicians the ability to treat patients with schizophrenia and bipolar mania without the adverse effects of the first-generation antipsychotics. In this article, the authors discuss the advantages and side effects of these agents and present a guide to help physicians choose the optimal drug in the most favorable formulation for each patient.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on